Shulou(Shulou.com)11/24 Report--

In the wave of science and technology in the 21st century, the intersection of artificial intelligence and biomedicine is becoming more and more obvious. It can analyze, predict and improve life and health in an unprecedented way. From gene editing to intelligent diagnosis, from drug research and development to personalized treatment, the combination of AI and biomedicine is opening a new era of intelligent medicine.

On September 10, the "AI + Biopharmaceutical Innovation and Development Summit Forum and Huawei developer Competition Shenzhen Award presentation ceremony" was successfully held in Shenzhen. Focusing on the theme of "Zhihui medicine, cloud gathering new life", the summit gathered industry experts to discuss the new trend of AI technology + biomedical industry integration and interpret the new trend of future development around the directions of digital innovation, industrial frontier hotspots and regional ecological development of the biomedical industry.

Go up against the wind and see the new development of biomedical industry

At the beginning of the meeting, Xiao Zuping, member of the party group and deputy director of the Shenzhen Municipal Bureau of Industry and Information Technology, delivered a speech, pointing out that Shenzhen attaches great importance to the strategic opportunities for the development of artificial intelligence. "one regulation, one plan, one list and one group" has formed a supporting pattern for the development of the artificial intelligence industry. Developers are the driving force for the development of innovative industry ecology, and developer ecological construction is the cornerstone of the successful innovation and application of digital industry. "Shenzhen will, as always, fully support the development of Huawei, the ecological construction of Huawei developers and the development of artificial intelligence. We warmly welcome Huawei developers to invest in Shenzhen and jointly create a new field for the development of artificial intelligence."

(Xiao Zuping, Party member and Deputy Director of Shenzhen Municipal Bureau of Industry and Information Technology)

Kang Ning, president of Huawei Cloud Global Ecology Department, said that in the face of emerging global public health security challenges, we need to accelerate the research and development of vaccines and drugs through technological innovation, and improve the accuracy of diagnosis and treatment. Build a complete knowledge system and disseminate medical information. Huawei has always been promoting the deep integration of digital technology and life, and through digital and intelligent enabling, it can bring innovation and change to the biomedical field. "We encourage developers to actively explore how to make full use of the ancient Huawei cloud disk model, apply it to biomedicine, promote innovation and improve people's health."

(Corning, president of Huawei Cloud Global Ecology Department)

"Competition to promote innovation and development, cooperation to Huan industrial rebirth", Huawei Cloud is committed to working with partners to build the future of ICT, so that more innovation results enable the industrial ecology. Chen Hang, general manager of Huawei Cloud Shenzhen, Yi Luping, general manager of Shenzhen Rabbit Exhibition Intelligent Technology Co., Ltd., Hu Wei, chairman of Shenzhen Kuajuajing Technology Co., Ltd., and Ni Haiyan, general manager of dandelion Shenzhen Pharmaceutical Service Co., Ltd., co-founder and chief scientist Yuan Chenguang of Shenzhen Xianggen Biology Co., Ltd., Ma Heting, chairman of Shenzhen Baikang Technology Co., Ltd. Wang Shengyuan, Deputy General Manager of Shenzhen Bay Baolong Biological Innovation Investment and Development Co., Ltd., signed the Pangu Model Joint Innovation Cooperation Agreement. In Shenzhen Industry and Information Technology Bureau Party member and Deputy Director Xiao Zuping, Director of Shenzhen Science and Technology Commission High-tech Industry Promotion Center Wang Hui, Shenzhen Nanshan District Science and Technology Innovation Bureau Deputy Director Luo Linjiao, Shenzhen Bay Baolong Company Chairman Deng Yingping, Huawei Cloud Global Ecology President Kang Ning, Huawei Cloud developer Alliance Product Department and Cloud Application Store Director Wang Xihai, Under the witness of he Ming, Product Director of Huawei Cloud IoT Service Product Department Open a new joint venture with Huawei Cloud and inject new momentum into the high-quality development of the industry.

AI + biomedical two-way empowerment, high-quality development of industry set sail

Focusing on "two-way enabling of AI and biomedicine", Pan Yi, dean of the School of computer Science and Control Engineering of Shenzhen University of Technology and chief scientist of Shenzhen Institute of Advanced Technology of the Chinese Academy of Sciences, said that a large amount of data has been accumulated in the field of drug research and development, and artificial intelligence has been gradually applied to drug discovery target mining, virtual screening, compound design and synthesis, ADME-T property prediction and physicochemical property prediction. The combination of AI and biomedicine will bring huge potential application space for clinical new drug trials.

(pan Yi, dean of the School of computer Science and Control Engineering, Shenzhen University of Technology and chief scientist of Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences)

After months of competition, the Shenzhen Division of the 2023 Huawei developer Competition officially ushered in the final. A total of 24 teams from the main defense venue of Nanshan District Innovation Center, Kunpeng Industrial Source Innovation Center and Longgang Industrial Internet Innovation Center won the prize, of which 12 teams were promoted to the regional competition.

At the award ceremony, Pan Yi, dean of the School of computer Science and Control Engineering of Shenzhen University of Technology and chief scientist of Shenzhen Academy of Advanced Technology of the Chinese Academy of Sciences, Wang Xihai, director of the Product Department and Cloud Application Store of Huawei Cloud developers Alliance, Wang Hui, director of the High-tech Industry Promotion Center of Shenzhen Science and Technology Innovation Commission, Chen Hang, general manager of Huawei Yun Shenzhen, and Chen Xiaofeng, head of the Health Department of the Talent Research Institute of the Organization Department of the Communist Party of China. Yang Jinwu, General Manager of Shenzhen Nanshan Qianhai Business Department, Luo Linjiao, Deputy Director of Science and Technology Innovation Bureau of Nanshan District, Shenzhen, he Ming, Product Director of Huawei Cloud IoT Service Product Department, Deng Yingping, Chairman of Shenzhen Bay Baolong Company, Qin Tiantian, Huawei Yun Shenzhen CTO, Li Jie, Assistant Director of High-tech Industry Promotion Center of Shenzhen Science and Technology Innovation Commission, Liu Yupeng, General Manager of Huawei Yun Shenzhen Industrial Development and Energy Cloud. Chen Zhiming, general manager of Kunpeng Industrial Source Innovation Center (Shenzhen) Co., Ltd., and Xiao Weiguang, general manager of Huawei Yun Shenzhen Ecological Development and Operation Department, certificates and prizes were awarded to the first prize, the second prize and the third prize of the enterprise track and the student track of this competition, and nearly 10 biomedical competition works won prizes. this moment of honor was witnessed by industry, enterprises, research experts and representatives.

(2023 Huawei developer Competition Shenzhen Division first prize-winning enterprise track and student track)

With creativity as the sail and technology as the anchor, developers strive for the top, releasing unlimited value for the integration and innovation of artificial intelligence and Internet of things information technology in the field of biomedicine.

AI and Biomedicine go both ways to explore the era of Intelligent Medicine

Nowadays, auxiliary drug design has become the key for the pharmaceutical industry to overtake in the bend in the wave of AI. Du Qi, a technical expert of Huawei Yunpangu model, introduces Huawei Yunpangu model 3.0 and Pangu auxiliary pharmaceutical platform under the title of Pangu model enabling the rebirth of biomedical industry. It is understood that Pangu auxiliary pharmaceutical platform can support the whole process and scene of drug design in one stop, improve the efficiency of drug research and development, and reduce the threshold of drug design. Powerful computing power, accurate algorithms and efficient data processing capabilities will press the "shortcut key" for drug research and development.

(du Qi, a technical expert on the ancient model of Huawei Yunpan)

Chen Guang Yuan, co-founder and chief scientific officer of Shenzhen Xianggen Biotechnology Co., Ltd., gave a speech on AI technology and the design of cyclopeptide drugs. Starting from the development trend of polypeptide innovative drugs, he introduced the latest global cyclopeptide drug research and development route. It also explains the experimental processes such as "cyclization of cyclic peptides: (a) and (B) types" and "transforming rich drug synthesis literature into the design and synthesis of cyclic peptides". " We will be guided by the latest global MOA research results, and strive to develop a number of classic drugs to address clinical needs, computing-driven innovative drug research and development. "

(Chenguang Yuan, co-founder and chief scientific officer of Shenzhen Xianggen Biotechnology Co., Ltd.)

Nie Yanling, Chief solution architect of Hongmeng Industry of Huawei Cloud IoT Service products Department, interprets the development trend of pharmaceutical industry and introduces Huawei cloud pharmaceutical industry solutions around the theme of Huawei cloud-assisted pharmaceutical industry manufacturing digital transformation. He said that at present, there are still shackles in the digital transformation of pharmaceutical enterprises. in this regard, Huawei Cloud starts from the empowered pharmaceutical manufacturing industry, focuses on the core link of the "man-machine material law ring", and creates a "smart factory" driven by data. help to reconstruct the competitiveness of enterprises and give birth to a new mode of intelligent production of biomedicine.

(nie Yanling, Chief solution architect, Hongmeng Industry, Huawei Cloud IoT Service products Department)

AI bright empowering, renovating intelligent medicine. The conference brings together cutting-edge insights and innovative achievements from industry, university, research and other dimensions, adding new wisdom and momentum to the development of "AI + biomedicine". At the same time, Huawei Yunpan ancient model has turned AI into a general technology, which can well serve thousands of industries and empower scientific research.

In the future, Huawei Cloud will continue to explore more possibilities of "AI + biomedicine", and will continue to give full play to its advantages in product resources, services and technology, so as to insert "digital wings" for industries in Shenzhen and more regions across the country, helping enterprises to release more value in the digital tide and work together to go to a new world of high-quality development.

Welcome to subscribe "Shulou Technology Information " to get latest news, interesting things and hot topics in the IT industry, and controls the hottest and latest Internet news, technology news and IT industry trends.